Clinical utility of <it>PKD2</it> mutation testing in a polycystic kidney disease cohort attending a specialist nephrology out-patient clinic
<p>Abstract</p> <p>Background</p> <p>ADPKD affects approximately 1:1000 of the worldwide population. It is caused by mutations in two genes, <it>PKD1</it> and <it>PKD2</it>. Although allelic variation has some influence on disease severity, genic...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-08-01
|
| Series: | BMC Nephrology |
| Online Access: | http://www.biomedcentral.com/1471-2369/13/79 |